BrainEver
PrivateLast Round
Grant
Jun 8, 2022
Total Funding Raised
$27.53M
Company Overview
BrainEver operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Grant round in June 2022.
BrainEver is a biotechnology company that develops innovative therapies for neurodegenerative diseases using homeoprotein-based treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainEver Comparables
Compare BrainEver with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProJenX, Inc. | 80% | |
| AcuraStem | 78% | |
| Aclipse Therapeutics | 76% |
For institutional investors. Book with your work email.
BrainEver Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 8, 2022 | ||||
| Series A | Nov 23, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrainEver Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Turenne Groupe | Series A |
| iBionext | Series A |
| Bpifrance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2026
Grew 29% QoQ, from 21 to 27 employees.
- Jan 1, 2026
Monthly visitors grew 38% MoM.
For institutional investors. Book with your work email.
BrainEver Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrainEver's valuation, stock price, and market status.
Is BrainEver a public or private company?
BrainEver is a private company.
What is the current stock price of BrainEver?
BrainEver is a private company, so its shares have no public market price. Caplight tracks BrainEver's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrainEver worth (valuation)?
Valuation information for BrainEver is not publicly available.
Can I buy BrainEver stock?
BrainEver shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrainEver's last funding round?
BrainEver's most recent funding round was Grant on June 8, 2022.
Who are the main investors in BrainEver?
Key investors in BrainEver include European Innovation Council Fund.
Will BrainEver IPO soon?
No public IPO plans have been announced for BrainEver.
How can I track BrainEver secondary market activity?
Caplight tracks bids, offers, and trades in BrainEver's shares on secondary markets.